ofgentamicin, mitochondria isolated from the renal cortex ofgroup 2 rats had significantly higher rates of respiration supported by pyruvate-malate, succinate and N,N,N',N'-tetramethyl-p-phenyldiamine-ascorbate, higher rates of dinitrophenol-uncoupled respiration and greater acceptor control ratios than those measured in mitochondria isolated from the renal cortex of group 1 animals. Similarly, after 8 and 10 doses, renal cortex and renal cortical mitochondrial Ca++ content of group 2 was significantly lower than values observed in group 1. Thus, dietary calcium supplementation significantly protected against gentamicin-induced renal tubular cell injury and, consequently, gentamicin-induced acute renal failure.
The mechanism for this protective effect ofCa++ may relate to the manner in which this polycationic antibiotic interacts with anionic sites, primarily the acidic phospholipids of renal membranes. In this regard, Ca++ was found to be a competitive inhibitor both of '251-gentamicin binding to renal brush border membranes, the initial site of interaction between gentamicin and renal proximal tubule cells, with a composite inhibition constant (Kj) of 12 mM and of 125I-gentamicin binding to phosphatidic acid, an important membrane acidic phospholipid, with a Ki of 170 ,M. Dietary calcium supplementation, however, did not alter either peak renal cortical gentamicin levels or the time course to achieve peak levels compared with animals receiving gentamicin and normal diets, sug- gesting that the mechanism of Ca++ protection may not be related only to an inhibition of gentamicin binding to and uptake along the plasma membrane of the renal tubule cell. Instead, studies of maneuvers that alter the severity of gentamicin nephrotoxicity suggest that Ca++ loading may protect against gentamicin-induced renal tubular cell injury by preventing critical gentamicin-membrane interactions within the renal tubular cell. Placing rats on sodium-supplemented and sodium-deficient diets ameliorated and potentiated gentamicin nephrotoxicity, respectively. Sodium bicarbonate supplementation was no better than an equimolar supplementation with sodium chloride in ameliorating gentamicin nephrotoxicity, suggesting that the protective effect of CaCO3 appears to reside in Ca"+ and not the alkalinizing anion. Calcium supplementation was protective against gentamicin-induced excretory failure and renal cell injury in the presence of volume depletion produced with sodium-deficient diets but lost its protective effect in the presence ofvolume expansion produced with NaCl-supplemented diets. Since Introduction A recent study by Bennett and co-workers (1) has demonstrated that dietary calcium supplementation substantially ameliorated gentamicin-induced acute renal failure, as measured by serum creatinine and inulin clearance. Since renal excretory function may decline either from functional hemodynamic alterations or from structural renal tubular cell injury, it is presently unclear whether this protection results from less severe functional or less severe structural alterations within the kidney. In this regard, study of the pathogenesis of acute renal failure, particularly the study of differentiation between the relative contribution of functional nephronal events, such as altered glomerular blood flow and permeability, vs. the contribution of direct tubule cell injury, has long been hampered by the fact that cell injury in both toxic and ischemic acute renal failure as a rule is heterogeneous, affecting some types of tubule cells but not others. There have been few good methods applied to quantify the extent of tubule cell injury other than morphologic studies, which are prone to sampling errors, fixation artifacts, and grading difficulties. Evidence increasingly suggests that a variety of biochemical indices critical in developing cell injury, including renal cortical mitochondrial function and renal cortex and mitochondrial calcium content, can be useful quantitative indices of cell injury and correlate well with the degree of renal excretory failure (2) (3) (4) (5) . Accordingly, experiments were undertaken in this study to determine if dietary calcium loading protects against gentamicin nephrotoxicity by ameliorating the degree of renal tubule cell injury produced by this antibiotic.
The mechanism by which dietary calcium supplementation ameliorates gentamicin nephrotoxicity is presently unclear. Since gentamicin-induced plasma and subcellular membrane injury appear to be critical pathogenetic events in gentamicin nephrotoxicity (6) (7) (8) , Ca++ may be altering the manner in which gentamicin interacts with renal cellular membranes. In this regard, multiple binding sites for the aminoglycoside antibiotics have been characterized in a variety of membranes (9) (10) (11) (12) (13) . For developing toxicity, the high affinity site is most critical and has been recently identified as the acidic phospholipids ofthe membrane (9, 10 (14) , bacterial membranes (15) , plasma membranes (16) (17) (18) (19) (20) , and subcellular membranes (21) (22) (23) 
Methods

Membrane isolation
Renal BBMs were isolated by the divalent cation precipitation technique detailed previously (9, 24) . Magnesium was used as the precipitating divalent cation for those experiments testing the effect of calcium as an inhibitor of '251I-gentamicin binding to BBMs. Calcium was used as the precipitating cation for experiments testing magnesium as an inhibitor 1. Abbreviations used in this paper: ACR, acceptor control ratio; BBM, brush border membrane; BUN, blood-urea nitrogen; DNP, 2,4-dinitrophenol; PTH, parathyroid hormone; RR, ruthenium red; TMPD, NNN',N'-tetramethyl-p-phenylenediamine.
of the binding interaction. Marker enzyme assays demonstrated no difference between these two procedures on the purity of membrane preparation. The BBM to homogenate ratio for the BBM enzyme, alkaline phosphatase was 8.0; the ratio for the basolateral enzyme, Na-K-ATPase, was 0.4; the ratio for the endoplasmic reticulum enzyme, NADPH cytochrome c reductase, was <0.1; the ratio for the lysosomal enzyme, N-acetyl-f-D-glucosaminidase, was 0.15; the ratio for the mitochondrial enzyme, cytochrome c oxidase, was .0. 1. These values are similar to our previous reports (9, 24) and indicate substantial purity of the BBM fraction.
'25I-Gentamicin binding assays '25I-Gentamicin binding to isolated renal BBMs and to the acidic phospholipid, phosphatidic acid, were done by the same procedures described in detail in a previous report (9) . BBMs were added to an assay buffer solution containing 25 
Renal cortical gentamicin levels
Samples from renal cortical homogenates were frozen and thawed at least twice, diluted 1: 100 with 0.15% Triton-X in water and gentamicin levels in these diluted specimens were determined by a standard radioimmunoassay method (New England Nuclear, Boston, MA).
Mitochondrial isolation
Isolated renal cortical mitochondria were prepared using a procedure similar to that which we have used previously (25, 26 constant (KI) of 12 mM for calcium and a K, of 21 mM for magnesium.
Since the acidic phospholipids are the high affinity membrane binding sites for gentamicin, the effect of calcium on '251I-gentamicin binding to the acidic phospholipid, phosphatidic acid, in a water/organic solvent partitioning system was assessed. Calcium inhibited this binding reaction ( excretory failure induced by gentamicin, as assessed by BUN. BUN values averaged 18±1 (SEM) and 14±0.2 after two doses, 21±0.4 and 16±0.7 (P < 0.01) after four doses, 36±6 and 27±5 (P < 0.001) after six doses, 120±20 and 41 ± 17 (P < 0.02) after eight doses, and 213±15 and 25±3 (P < 0.001) after 10 doses for groups 1 and 2 animals, respectively.
Renal cortical mitochondrial respiratory function. Renal cortical mitochondria, like those from other tissues, avidly transport calcium into their matrices (28) . Mitochondria may thus gain calcium during their isolation. Since increases in mitochondrial calcium content may be detrimental to mitochondrial function (8) , the use of methods that attempt to limit calcium uptake during the mitochondrial isolation procedure is critical in obtaining a mitochondria preparation in vitro reflective of mitochondrial function in situ. In this regard, a homogenizing solution containing both 1 supplemented group than in the standard diet group. And after § P < 0.01 (group 2 relative to group 1). 10 doses, all mitochondrial respiratory parameters were protected P < 0.001 (group 2 relative to group 1).
by calcium supplementation.
Renal cortical homogenate and mitochondrial calcium contents. Since dying cells lose their ability to control intracellular Fig. 6 ). After six doses, respiration supported by TMPD-ascorbate calcium within normally low levels, injured cells develop prowas better preserved in group 2 compared with group 1. After gressive degrees ofcalcium overload, so that tissue calcium coneight doses, most respiratory values were better in the calciumtent reflects the degree of cell necrosis (2, 3, 7, 8) . In this regard, 139 Cakium Protects against Gentamicin Nephrotoxicity 4% calcium-supplemented diets. n = 4-6 in each group. than the BUN level of 36±6 in rats on standard diets (group 7). Calcium loading in the setting ofsodium depletion, however, protected against the gentamicin-induced rise in BUN. Animals on sodium-deficient diets receiving calcium supplementation (group 9) had a BUN level of 31+7, a value significantly lower (P < 0.001 ) than that of group 8 but no different from that of group 7. Thus, calcium supplementation ameliorated gentamicin-induced declines in renal excretory function only in sodium depleted but not sodium-loaded animals.
Renal cortical mitochondrial respiratoryfunction. Table V displays all mitochondrial respiratory parameters for groups 3-9. After eight doses, sodium supplementation with NaCl (group 4) ameliorated several, but not all, gentamicin-induced declines in mitochondrial respiratory parameters observed in animals on standard diets (group 3). The addition of CaCO3 to the diet (group 5), however, resulted in no further amelioration than that seen with NaCI loading alone. Sodium supplementation with NaHCO3 (group 6), however, maintained renal cortical mitochondrial function during developing gentamicin nephrotoxicity much better than NaCl, since all mitochondrial absolute respiratory rates of group 6 animals were significantly better than those from group 3 animals, whereas only the ACRs were significantly higher in group 4 compared with group 3. Thus, bicarbonate appeared to provide an additional benefit to 141 Calcium Protects against Gentamicin Nephrotoxicity sodium loading in protecting from gentamicin-induced renal cortical mitochondrial dysfunction.
On the other hand, sodium depletion potentiated gentamicininduced renal injury. After six doses, renal cortical mitochondrial respiratory functions from animals on sodium-deficient diets (group 8) were significantly more impaired compared with those from rats on standard diets (group 7). In contrast to the lack of effect of calcium supplementation during sodium loading, calcium supplementation during sodium deprivation (group 9) resulted in protecting against almost all mitochondrial respiratory declines induced by gentamicin.
Renal cortical homogenate and mitochondrial calcium content. Table VI summarizes calcium content data from groups 3-9. Sodium loading with NaCl (group 4) prevented the large increases in homogenate and mitochondrial calcium content observed in animals on standard diets (group 3) after eight doses of gentamicin. Calcium supplementation (group 5) or sodium supplementation with NaHCO3 (group 6) did not add further to the protection from cellular and mitochondrial calcium overload afforded by NaCl supplementation (group 4), since renal cortical homogenate and mitochondrial calcium content values from groups 5 and 6 were not significantly different from group 4 values.
After six doses of gentamicin, sodium depletion (group 8) significantly increased homogenate and mitochondrial calcium content values compared with those from rats on standard diets (group 7). Calcium supplementation during sodium deprivation (group 9) prevented the potentiation of cellular and mitochondrial calcium overload produced by sodium depletion. Values from group 9 were significantly lower than those from group 8.
Discussion
The divalent cations, Ca"+ and Mg", have been clearly shown to alter a variety ofaminoglycoside-membrane events. The aminoglycosides inhibit calcium binding to artificial phospholipid membranes (14) . Calcium and magnesium diminish aminoglycoside binding and transport by bacterial membranes (15) . Aminoglycosides alter inner mitochondrial membrane function in vitro primarily by displacing Mg"+ from sites along the inner mitochondrial membrane that control monovalent cation permeability, and Mg"+ can reverse these effects (21, 22) . Gentamicin also inhibits mitochondrial Ca"+ uptake (23) . Gentamicin interferes with the slow calcium channels of the sarcolemma in the atrial myocardium of guinea pigs (16) . Gentamicin inhibits the glucose transporter of isolated BBM vesicles in vitro and this inhibition is prevented by magnesium (19). Likewise, the inhibition of the antidiuretic hormone-responsive adenylate cyclase of the toad urinary bladder by gentamicin is prevented by Mg++ (20) . Thus, there is ample evidence that divalent cations modify aminoglycoside-membrane interactions and may prevent many aminoglycoside-induced membrane alterations and aminoglycoside-induced toxicities. In this regard, aminoglycosideinduced neuromuscular blockade is due to displacement of membrane-bound calcium, resulting in an inhibition ofthe prejunctional release of acetylcholine (17) and a decrease in the sensitivity of the motor end plate to the depolarizing action of acetylcholine (18) . This blockade is reversed by Ca++ (18) . Calcium also acutely prevents gentamicin-induced loss of cochlear microphonics in vitro (33) . These reports demonstrate the ability of divalent cations to prevent and reverse aminoglycoside-induced neurotoxicity and ototoxicity acutely in vitro. In a similar fashion, recent reports (1, 34) have demonstrated that oral calcium loading protects against gentamicin-induced acute renal excretory failure. The present experiments were undertaken to better characterize the effect of dietary calcium supplementation to ameliorate aminoglycoside-induced nephrotoxicity. To increase Ca++ delivery to the kidney, rats were placed on a standard rat chow diet supplemented with 4% Ca++ by weight in the form of CaCO3. This dietary manipulation has been demonstrated to increase urinary calcium excretion >10-to 20-fold (34, 35) . Calcium supplementation in this manner dramatically ameliorated the gentamicin-induced decline in renal excretory function, as measured by elevations in BUN, observed in rats on standard diets. This finding confirms the protective effect of f P < 0.05, group 4 or 5 vs. group 3. § P < 0.02, group 4 or 5 vs. group 3. I I P < 0.001, group 6 vs. group 4. T P < 0.02, group 6 vs. group 4. ** P < 0.05, group 6 vs. group 4.
ff P < 0.01 group 8 vs. group 7. § § P < 0.02 group 8 vs. group 7. 1 1 11 P < 0.05 group 8 vs. group 7. TT P < 0.01 group 9 vs. group 8.
oral calcium loading on gentamicin-induced renal excretory failure recently reported by Bennett and co-workers (1, 34) .
Calcium supplementation may ameliorate gentamicin-induced declines in renal excretory function and increases in BUN by either alleviating functional hemodynamic alterations at the glomerular level (36) or preventing structural cellular damage at the tubular level. If calcium was preventing the activity of gentamicin interactions with renal membranes to mediate membrane dysfunction, tubular cell injury, and, eventually, renal excretory failure, then the degree of renal tubular cell injury should be less in the calcium-supplemented group. In approaching this issue, however, broader questions arise, primarily because in attempting to understand the pathogenesis of the decline in renal excretory function in both nephrotoxic and ischemic acute renal failure, much of the work over the past two decades has focused on the nephronal determinants ofrenal excretory failure during acute renal failure. These determinants have been intratubular obstruction, backleak of glomerular filtrate through damaged tubular epithelium, and primary alterations in the hemodynamic factors controlling glomerular filtration. Although understanding the nephronal mechanisms for acute renal failure has been extremely elucidative, it is clear that the final common pathogenetic pathway for the development of either ischemic or nephrotoxic acute renal failure is renal tubular cell injury (6) (7) (8) . Without renal cell injury, the various factors responsible at the nephronal level for excretory failure of the kidney would not be initiated. Ultimately, the understanding of the pathogenesis of acute tubular necrosis resides in the understanding of the critical biochemical alterations responsible for the loss of renal cell integrity, but only recently have these biochemical events become areas of increased investigation, so that the manner in which to best quantitatively assess the magnitude of renal tubular cell injury in developing injury has not been well defined. Morphologic studies have been useful but they are prone to sampling errors, fixation artifacts, and grading difficulties. Additionally, substantial functional changes may occur before necrosis. Increasing evidence suggests that nephrotoxins and ischemia exert their primary detrimental effects on cells by disturbing the membrane phase of the cell (6) (7) (8) . Both the plasma membrane and the intracellular organellar membranes are potential sites of toxicity. Ofthe subcellular membranes, because of the high metabolic demands of epithelial transport, the mitochondrial membrane assumes primary importance in the renal tubular cell. Recent studies from our lab- Since dying cells lose their ability to control intracellular calcium within normally low levels, injured cells develop progressive degrees of calcium overload, and the calcium content found in renal cortical homogenates can help quantitate the extent of advanced renal tubular cell injury present (2) (3) (4) (5) . The data in this study by demonstrating a strong correlation between the declines in renal excretory function, as measured by BUN, and the degree of renal proximal tubular cell injury, as measured by renal cortical homogenate calcium Renal cortical mitochondrial function is also significantly altered in developing nephrotoxic acute renal failure (3, 26, 37, 38) and has been used, along with renal cortex homogenate calcium content, as a quantitative guide to the extent of renal cell damage in developing acute renal failure (2) (3) (4) (5) (6) (7) (8) . After four doses, mitochondrial function from rats on both standard and calcium-supplemented diets (groups 1 and 2) was altered. These derangements reflect early alterations preceding loss of renal tubular cell integrity, as assessed morphologically, and precede organ failure, as measured by a rise in BUN, and occur before mitochondrial and cellular calcium overload. The time course for these changes in gentamicin nephrotoxicity has been detailed previously (3, 37) . Renal cortical mitochondrial respiratory parameters from both groups progressively worsened with increasing dosage, so that after six doses all respiratory parameters were significantly lower in group 1 compared with control values.
Respiration supported by pyruvate-malate, succinate and TMPD-ascorbate were all substantially affected, demonstrating major derangements along all segments ofthe electron transport chain of the inner mitochondrial membrane (8) . This further progressive deterioration in mitochondrial function is related to the occurrence of mitochondrial calcium overload, which develops as the extent and degree of cell injury progresses (3) . Using mitochondrial dysfunction as a parameter of renal tubular cell injury, after eight doses, significant differences in most respiratory parameters between groups I and 2 were observed. After 10 doses, all respiratory parameters were significantly better in mitochondria isolated from rats on calcium-supplemented diets than in organelles isolated from animals on standard diets. Calcium supplementation clearly preserved renal cortical mitochondrial function in the later stages of gentamicin nephrotoxicity.
The mechanism by which calcium loading ameliorates gentamicin nephrotoxicity is presently unclear. Since gentamicininduced plasma and subcellular membrane injury appear to be critical pathogenetic events in gentamicin nephrotoxicity (6) (7) (8) , Call may be competitively inhibiting critical gentamicin-renal membrane interactions that lead to cell injury. In this regard, multiple binding sites for the aminoglycoside antibiotics have been characterized in a variety of membranes (9) (10) (11) (12) (13) . For developing toxicity, the high affinity site is most critical and has been recently identified as the acidic phospholipids ofthe membrane (9, 10) . This binding reaction is due to a charge interaction between these polycationic antibiotics and the anionic head groups of acidic phospholipids. Not (6) , differences in a small but actively toxic pool ofgentamicin may exist but may be difficult to demonstrate quantitatively.
Another possibility may be that Ca"+ prevents critical cellular derangements induced by gentamicin within the renal tubular cell rather than on its cell surface. Since gentamicin has been demonstrated to induce alterations in the structure and function of a variety of subcellular membranes produced by the antibiotic (21, 22, 24) , prevention by calcium of subcellular membrane dysfunction may be an additional mechanism for its protective effect. That Ca"+ may be having a major subcellular effect to prevent gentamicin-induced renal cell injury is suggested by the influence dietary sodium manipulations had on the protective effect of oral calcium loading. Since sodium and calcium transport are directly linked to one another along the proximal tubule, volume expansion leads to inhibition of Ca"+ transport and sodium depletion leads to elevations in Ca"+ transport along the proximal tubule (31) . In this regard, sodium supplementation with NaCl ameliorated gentamicin toxicity, as measured by elevations in BUN, declines in mitochondrial respiratory parameters, and increases in homogenate and mitochondrial calcium content. In the presence of volume expansion with NaCl loading, however, calcium supplementation did not further ameliorate gentamicin-induced renal excretory failure and renal cell injury than that seen with NaCl loading alone. In fact, all absolute respiratory rates from mitochondria isolated from volume-expanded rats receiving Ca"+ supplementation (group 5) were more affected than those from non-volume-expanded animals receiving standard Ca"+ supplemented diets (group 2) after eight doses of gentamicin; furthermore, higher homogenate and mitochondrial calcium contents were found in group 5 than in group 2 after either eight or 10 doses. Thus, calcium loading in the presence of volume expansion, which would diminish reabsorptive rates for calcium along the proximal tubule, was not as protective against renal cell injury as calcium loading in the standard diet state. However, because the degree of renal tubular cell injury and renal excretory failure produced by gentamicin during sodium supplementation was not severe, an additional protective effect of oral calcium loading in this group may not be apparent.
Sodium depletion, on the other hand, potentiated gentamicin nephrotoxicity. The degree of renal injury that developed after 10 doses in rats on standard diets (group 1) was similar to that occurring after only six doses in animals on sodium-deficient diets (group 8) . This potentiation has been reported previously (30) . Calcium supplementation in this setting provided significant protection against gentamicin-induced renal excretory failure, as measured by BUN, and renal cell injury, as measured by mitochondrial function and homogenate and mitochondrial calcium content. Calcium loading in the setting of sodium depletion, a state in which Ca'+ reabsorption is increased along the proximal tubule, retained its protective effect against gentamicin nephrotoxicity.
Finally, calcium supplementation was accomplished in these studies by the addition of CaCO3 to the diet. Not only is the cation, Ca', ingested but also its accompanying alkaline anion, CO-2. Alkalinization with HCO-loading has been associated both with improvement and no improvement of gentamicininduced acute renal failure in previous reports (32, 43) . In this study, NaHCO3 supplementation was no better than an equimolar supplementation with NaCl in protecting against a rise in BUN or homogenate and mitochondrial calcium content but was slightly better in protecting against mitochondrial injury. No major protective role for HCO-alone on gentamicin nephrotoxicity could thus be demonstrated in this study, suggesting that the protective effect of CaCO3 supplementation on gentamicin nephrotoxicity appears to reside primarily in Ca'.
The protective role of Ca'+ in this form of toxin-induced cell injury contrasts to the detrimental effects of mitochondrial and cellular Ca'+ overload on cell viability in most forms of ischemic and toxic cell injury (7, 8, 44) . In this regard and of considerable importance are the recent preliminary findings that demonstrated that major elevations in serum Ca'+ levels and renal tubular flux of Ca'+ potentiate gentamicin-induced acute renal failure by increasing the rate of development of tissue and mitochondrial Ca' overload (45) . In view ofthis data, it appears that the protective role of dietary calcium supplementation in aminoglycoside-induced toxic cell injury resides in the unique competitive role of this divalent cation to inhibit toxin-membrane interactions and its ability to only modestly increase serum levels and proximal tubular flux of Ca'.
Dietary calcium supplementation may ameliorate gentamicin-induced renal damage by additional mechanisms. This dietary manipulation may increase luminal urine flow secondary to a solute diuresis resulting in a lower intraluminal gentamicin concentration, a decrease in renal cortex concentration of the antibiotic, and a lesser toxic effect, such as occurs with the protection afforded by the natriuresis during a high sodium diet. In this regard, recent reports have demonstrated that adult rats placed on a 4% calcium-supplemented diet do not develop a solute or sodium diuresis (1, 34, 35) , so that it is unlikely that the protective effect of this diet is mediated by the development ofa solute diuresis. A decline in circulating parathyroid hormone (PTH) levels may also participate in the effect. PTH has been shown to increase the levels of acidic phospholipids in the renal cortex (46, 47) . Suppression of PTH release by oral calcium loading may result in a decline in the number of high affinity binding sites in the renal tubular cell, diminish gentamicinmembrane interactions, and reduce the toxic potential of the antibiotic. Recent data suggest that this possibility is also unlikely (48) . A final possible factor that may contribute to this protective effect may be related to the phosphate ion. A recent study has shown that dietary calcium supplementation produces phosphate depletion and declines in serum phosphate (49) . Since cellular calcium overload, occurring in part as calcium phosphate, is an important determinant of the time course and degree of cell injury (44) , declines in serum and cellular phosphate may lessen the amount of cellular calcium overload and, thus, the degree of cell injury produced by a toxic or ischemic event. Certainly, phosphate loading has been shown to potentiate acute renal failure (50) . Future studies will undoubtedly shed further insight into these possibilities.
In summary, these experiments have: (a) confirmed that dietary calcium loading protects against gentamicin-induced acute renal failure, (b) determined that this protection is based upon amelioration of the degree of gentamicin-induced renal tubule cell injury as assessed by several critical biochemical parameters, and (c) suggested that this protective effect is consistent with an ability of Ca"+ to act as a competitive inhibitor of gentamicin-renal membrane interactions primarily at subcellular rather than cell surface sites ofthe renal proximal tubule cell.
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